Search engine for discovering works of Art, research articles, and books related to Art and Culture
Javascript must be enabled to continue!
Alzheimer’s Disease
View through CrossRef
Advances in the current management and treatment of Alzheimer’s disease have grown directly from our increased understanding of the neurobiology underlying this disease. Currently available pharmacologic and nonpharmacologic treatment strategies remain focused on symptomatic management of disease rather than disease modification. Despite a wealth of evidence supporting the clinical benefits of existing therapies in the management of symptomatic progression, there is limited evidence that these available therapies modify disease progression over the course of dementia progression. More recent research discoveries in the areas of genetics, molecular and cell biology, and environmental risk factors have become the focal point for an explosive growth in experimental disease-modifying strategies designed to prevent, slow, or potentially halt the progression of Alzheimer’s disease.
Title: Alzheimer’s Disease
Description:
Advances in the current management and treatment of Alzheimer’s disease have grown directly from our increased understanding of the neurobiology underlying this disease.
Currently available pharmacologic and nonpharmacologic treatment strategies remain focused on symptomatic management of disease rather than disease modification.
Despite a wealth of evidence supporting the clinical benefits of existing therapies in the management of symptomatic progression, there is limited evidence that these available therapies modify disease progression over the course of dementia progression.
More recent research discoveries in the areas of genetics, molecular and cell biology, and environmental risk factors have become the focal point for an explosive growth in experimental disease-modifying strategies designed to prevent, slow, or potentially halt the progression of Alzheimer’s disease.
Related Results
Neurobiology of Alzheimer‘s Disease
Neurobiology of Alzheimer‘s Disease
Abstract
Alzheimer’s disease is the most common form of dementia in the elderly; 450,000 people in the UK and 4.5 million people in the USA suffer with this disea...
Tratamentos da Doença de Alzheimer: Perspectivas e Bioética
Tratamentos da Doença de Alzheimer: Perspectivas e Bioética
A Doença de Alzheimer (DA) é um distúrbio neurodegenerativo progressivo associado com um acúmulo de placas da proteína beta amiloide (Aβ) senis extracelulares e o excesso de emaran...
Alzheimer's Disease (Oxford Neurology Library)
Alzheimer's Disease (Oxford Neurology Library)
Providing clinicians with the latest developments in research, this new edition of Alzheimer's Disease is a succinct and practical introduction to the diagnosis, evaluation, and ma...
Dementia 1: Defining Dementia, Alzheimer’s Disease and Frontotemporal Dementia (DRAFT)
Dementia 1: Defining Dementia, Alzheimer’s Disease and Frontotemporal Dementia (DRAFT)
The video in this chapter explores dementia, and focuses on definitions of dementia, Alzheimer’s disease and Frontotemporal Dementia. Dementia is defined as a cognitive decline in ...
Rheumatoid arthritis—management
Rheumatoid arthritis—management
Influential guidelines on rheumatoid arthritis (RA) management agree on most key recommendations. Early diagnosis of persistent synovitis, and identification of poor prognostic mar...
A History of Multiple Sclerosis
A History of Multiple Sclerosis
While we now recognize that MS is a common neurological disease, as late as the early twentieth century it was considered a relatively rare condition in Europe and the United State...
Disclosing the diagnosis of Alzheimer’s disease
Disclosing the diagnosis of Alzheimer’s disease
Diagnostic disclosure of Alzheimer’s disease is generally accepted to be good practice; however, there are important factors for clinicians to consider when preparing to impart suc...